SARS-CoV-2 mRNA vaccine induces robust specific and cross-reactive IgG and unequal neutralizing antibodies in naive and previously infected people

Understanding vaccine-mediated protection against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is critical to overcoming the global coronavirus disease 2019 (COVID-19) pandemic. We investigate mRNA-vaccine-induced antibody responses against the reference strain, seven variants, and s...

Descripción completa

Detalles Bibliográficos
Autores principales: Narowski, Tara M., Raphel, Kristin, Adams, Lily E., Huang, Jenny, Vielot, Nadja A., Jadi, Ramesh, de Silva, Aravinda M., Baric, Ralph S., Lafleur, John E., Premkumar, Lakshmanane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769879/
https://www.ncbi.nlm.nih.gov/pubmed/35090596
http://dx.doi.org/10.1016/j.celrep.2022.110336

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769879/
https://www.ncbi.nlm.nih.gov/pubmed/35090596
http://dx.doi.org/10.1016/j.celrep.2022.110336

Ejemplares similares